Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia.

Leucht S, Komossa K, Rummel-Kluge C, Corves C, Hunger H, Schmid F, Asenjo Lobos C, Schwarz S, Davis JM.

Am J Psychiatry. 2009 Feb;166(2):152-63. doi: 10.1176/appi.ajp.2008.08030368. Epub 2008 Nov 17.

PMID:
19015230
2.

Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.

Rummel-Kluge C, Komossa K, Schwarz S, Hunger H, Schmid F, Lobos CA, Kissling W, Davis JM, Leucht S.

Schizophr Res. 2010 Nov;123(2-3):225-33. doi: 10.1016/j.schres.2010.07.012. Epub 2010 Aug 7. Review.

3.

Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons.

Rummel-Kluge C, Komossa K, Schwarz S, Hunger H, Schmid F, Kissling W, Davis JM, Leucht S.

Schizophr Bull. 2012 Jan;38(1):167-77. doi: 10.1093/schbul/sbq042. Epub 2010 May 31. Review.

4.

Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.

Samara MT, Dold M, Gianatsi M, Nikolakopoulou A, Helfer B, Salanti G, Leucht S.

JAMA Psychiatry. 2016 Mar;73(3):199-210. doi: 10.1001/jamapsychiatry.2015.2955.

5.

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.

Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, Samara M, Barbui C, Engel RR, Geddes JR, Kissling W, Stapf MP, Lässig B, Salanti G, Davis JM.

Lancet. 2013 Sep 14;382(9896):951-62. doi: 10.1016/S0140-6736(13)60733-3. Epub 2013 Jun 27. Review. Erratum in: Lancet. 2013 Sep 14;382(9896):940.

PMID:
23810019
6.

Are there any differences in the efficacy among second generation antipsychotics in the treatment of schizophrenia and related disorders?

Motlová L, Spaniel F, Höschl C, Balon R.

Ann Clin Psychiatry. 2007 Apr-Jun;19(2):133-43. Review.

PMID:
17612853
7.

Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.

Chakos M, Lieberman J, Hoffman E, Bradford D, Sheitman B.

Am J Psychiatry. 2001 Apr;158(4):518-26.

PMID:
11282684
8.

Zotepine versus other atypical antipsychotics for schizophrenia.

Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Kissling W, Leucht S.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006628. doi: 10.1002/14651858.CD006628.pub2. Review. Update in: Cochrane Database Syst Rev. 2010;(10):CD006628.

PMID:
20091601
9.
10.
11.

Meta-analyses of the efficacy of asenapine for acute schizophrenia: comparisons with placebo and other antipsychotics.

Szegedi A, Verweij P, van Duijnhoven W, Mackle M, Cazorla P, Fennema H.

J Clin Psychiatry. 2012 Dec;73(12):1533-40. doi: 10.4088/JCP.11r07596.

12.

Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia.

Rosenheck RA, Leslie DL, Sindelar J, Miller EA, Lin H, Stroup TS, McEvoy J, Davis SM, Keefe RS, Swartz M, Perkins DO, Hsiao JK, Lieberman J; CATIE Study Investigators.

Am J Psychiatry. 2006 Dec;163(12):2080-9.

PMID:
17151158
13.

Systematic Literature Review of the Methods Used to Compare Newer Second-Generation Agents for the Management of Schizophrenia: A focus on Health Technology Assessment.

Kruse G, Wong BJ, Duh MS, Lefebvre P, Lafeuille MH, Fastenau JM.

Pharmacoeconomics. 2015 Oct;33(10):1049-67. doi: 10.1007/s40273-015-0285-8. Review.

PMID:
25963579
14.

Quetiapine for schizophrenia.

Srisurapanont M, Maneeton B, Maneeton N.

Cochrane Database Syst Rev. 2004;(2):CD000967. Review.

PMID:
15106155
15.

Newer atypical antipsychotic medication versus clozapine for schizophrenia.

Tuunainen A, Wahlbeck K, Gilbody SM.

Cochrane Database Syst Rev. 2000;(2):CD000966. Review.

PMID:
10796559
16.

Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis.

Kemmler G, Hummer M, Widschwendter C, Fleischhacker WW.

Arch Gen Psychiatry. 2005 Dec;62(12):1305-12.

PMID:
16330718
17.

What do large scale studies of medication in schizophrenia add to our management strategies?

Agius M, Davis A, Gilhooley M, Chapman S, Zaman R.

Psychiatr Danub. 2010 Jun;22(2):323-8. Review.

18.

Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.

Maher AR, Theodore G.

J Manag Care Pharm. 2012 Jun;18(5 Suppl B):S1-20. Review.

PMID:
22784311
19.
20.

Antipsychotics in adults with schizophrenia: comparative effectiveness of first-generation versus second-generation medications: a systematic review and meta-analysis.

Hartling L, Abou-Setta AM, Dursun S, Mousavi SS, Pasichnyk D, Newton AS.

Ann Intern Med. 2012 Oct 2;157(7):498-511. Review.

PMID:
22893011

Supplemental Content

Support Center